Month: April 2020

SAN DIEGO, April 14, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., announced today the appointment of Shahe Garabedian as Senior Vice President of Quality Assurance and the issuance of an inducement award. “We are very pleased to welcome Shahe to the TRACON senior management team,” said Dr. Charles Theuer, President and Chief Executive Officer of TRACON. “He has a strong track record of successful quality oversight that includes the clinical, laboratory and manufacturing functional areas. Shahe’s extensive experience in these critical capacities...

ARTEFACTSociété Anonyme au capital de 3 383 170,00 €19 Rue Richer 75009 PARIS418 267 704 R.C.S. PARISDECLARATION MENSUELLE RELATIVE AU CAPITAL ET DROITS DE VOTEEn application des articles L.233-8 II du Code de commerce et223-16 du Règlement Général de l’Autorité des Marchés FinanciersA propos d’Artefact I artefact.com

ARTEFACTSociété Anonyme au capital de 3 383 170,00 €19 Rue Richer 75009 PARIS418 267 704 R.C.S. PARISCAPITAL AND VOTING RIGHTS MONTHLY DECLARATIONIn accordance with articles L233-8 of commercial law and223-16 of the General Regulation of the Financial Markets Authority (AMF)About Artefact I artefact.com

Company reports no anticipated COVID-19 impact on NORSE 1, its first registration clinical trial evaluating ONS-5010, an investigational ophthalmic formulation of bevacizumab, to treat wet AMD  Risk mitigation strategies being developed for possible one- to three-month delay related to COVID-19 for NORSE 2, the Company’s second registration clinical trial for ONS-5010 to treat wet AMD, depending on local emergency conditions CRANBURY, N.J., April 14, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the “Company”), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today provided a clinical update on the impact of the COVID-19 pandemic on the status of NORSE 1 and NORSE 2, its ongoing registration clinical...

WINNIPEG, Manitoba, 14 avr. 2020 (GLOBE NEWSWIRE) — La Corporation People (TSX Venture : PEO) (« People Corporation » ou la « Société »), annonce aujourd’hui qu’elle prévoit publier le lundi 27 avril 2020 à 6 h 30 HE ses résultats financiers pour le deuxième trimestre se terminant le 29 février 2020.La Corporation People tiendra une conférence téléphonique le lundi 27 avril 2020 à 8 h 30 HE pour discuter de ses résultats financiers et fournira aux investisseurs les principaux faits saillants de ses activités. La conférence téléphonique sera dirigée par Laurie Goldberg, président-directeur général et chef de la direction, et Dennis Stewner, directeur financier et chef de l’exploitation.DÉTAILS DE LA CONFÉRENCE TÉLÉPHONIQUEDate : Le 27 avril 2020 | Heure : 8 h 30 HENuméro à composer par les participants : 416 764-8688 ou 1 888...

Orlando, Florida, April 14, 2020 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), operator of IZEAx®, the premier online marketplace connecting brands and publishers with influential content creators, released its latest research initiative, “COVID-19 Stay-at-Home Impacts on Consumer Wellness” today. The U.S. consumer study examines the impacts of COVID-19 “Stay-at-Home” orders among those currently confined to their homes. It also focuses on the physical and mental health changes people have experienced since lockdown, as well as the impacts on their social media and purchasing behaviors.The new report is available to download for free, here: izea.com/covid19/consumer-wellnessIZEA fielded the study on April 9, 2020, as many U.S. consumers were entering their 2nd or 3rd week of home confinement. All of those who participated...

SUNNYVALE, Calif., April 14, 2020 (GLOBE NEWSWIRE) — Infinera Corporation (NASDAQ: INFN) today announced that Amy H. Rice, a managing director with Oaktree Capital Management, L.P. (“Oaktree”), has joined Infinera’s board of directors. In addition, Infinera, will further strengthen its board of directors through the appointment of an additional independent director, who will be chosen by Infinera in collaboration with Oaktree, in the near future. Through its affiliated investment funds, Oaktree beneficially owns approximately 14 percent of Infinera’s common stock.“We are delighted to further strengthen our relationship with Oaktree,” said Kambiz Y. Hooshmand, chairman of Infinera’s board of directors. “Since our acquisition of Coriant from investment funds managed by Oaktree, we have benefited from Oaktree’s collaborative approach...

WATERLOO, Ontario, April 14, 2020 (GLOBE NEWSWIRE) — Teledyne DALSA, a Teledyne Technologies [NYSE:TDY] company and global leader in digital imaging technology, is pleased to introduce its latest family of LWIR cameras, the Calibir™ GXM series. Using Teledyne DALSA’s own VGA 17um microbolometer technology, Calibir GXM cameras offer exceptional infrared imaging performance, with great sensitivity, outstanding dynamic range for wide temperature coverage, and factory-calibrated radiometric performance. Calibir delivers accurate, repeatable results for critical applications like detecting elevated skin temperature in fever screening.“As a key component in a well-designed thermal imaging system, the new GXM640 can aid in the detection of elevated skin temperature and fever screening. Its small form factor and architecture allows integrators...

PORTLAND, Maine, April 14, 2020 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced that it has received $938,000 in support from the federal government under the Paycheck Protection Program.Working with its partners at Gorham Savings Bank, the Company applied for and received this funding under the Keeping American Workers Paid and Employed Act, which was included in the $2.2 trillion CARES Act that was approved by Congress on March 25, 2020. The funding helps the Company maintain operations and meet payroll during this unprecedented time of global economic challenge related to the COVID-19 pandemic.This...

Lassila & Tikanoja plcInvestor News14 April 2020 3.00 pmLassila & Tikanoja plc will publish Interim Report January-March on Wednesday 28 April 2020 at 8.00 am. After publication, the release will be available on the company’s website at www.lt.fi/en.Lassila & Tikanoja will host a webcast for analysts, institutional investors and media on 28 April 2020 at 9.00 am Finnish time. The presentation material will be published on the company’s website.The Finnish briefing will be hosted by CEO Eero Hautaniemi and CFO Valtteri Palin.To join the webcast go to: https://webcast.reloadmedia.fi/quarterlyreport/?q=280420Please register a few minutes before the webcast using the same link.Lassila & Tikanoja will organize conference calls in English on request. If you are interested in having a conference call with the...